Re: The association between statins and cancer incidence in a veterans population [1]

Journal of the National Cancer Institute

Volumn 100, Issue 13, 2008, Pages 972-

  Platz, Elizabeth A ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROSTATE SPECIFIC ANTIGEN; ANTINEOPLASTIC AGENT; HYPOCHOLESTEROLEMIC AGENT;

CANCER CHEMOTHERAPY; CANCER GRADING; CANCER INCIDENCE; CANCER STAGING; CLINICAL TRIAL; COLORECTAL CANCER; HUMAN; LETTER; LUNG CANCER; MEDICAL CARE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; VETERAN; COLORECTAL TUMOR; EPIDEMIOLOGY; INCIDENCE; LUNG TUMOR; MALE; NEOPLASM; NOTE; PROSTATE TUMOR; STATISTICS; UNITED STATES;

ANTICHOLESTEREMIC AGENTS; ANTINEOPLASTIC AGENTS; BIAS (EPIDEMIOLOGY); COLORECTAL NEOPLASMS; CONFOUNDING FACTORS (EPIDEMIOLOGY); HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; LUNG NEOPLASMS; MALE; NEOPLASMS; PROSTATIC NEOPLASMS; UNITED STATES; VETERANS;

EID: 46849119806     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn159     Document Type: Letter

References (7)

1. Farwell WR, Scranton RE, Lawler EV, et al. The association between statins and cancer incidence in a veterans population. J Natl Cancer Inst. 2008;100(2):134-139.
2. Platz EA. Epidemiologic musing on statin drugs in the prevention of advanced prostate cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(24):2175-2180.
3. Friedman GD, Flick ED, Udaltsova N, Chan Pharm DJ, Quesenberry CP Jr, Habel LA. Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients. Pharmacoepidemiol Drug Saf. 2008;17(1):27-36.
4. Boudreau DM, Yu O, Buist DS, Miglioretti DL. Statin use and prostate cancer risk in a large population-based setting [published online ahead of print March 6, 2008]. Cancer Causes Control. doi: 10.1007/s10552-008-9139-4.
5. Browning DR, Martin RM. Statins and risk of cancer: a systematic review and metaanalysis. Int J Cancer. 2007;120(4):833-843.
6. Shannon J, Tewoderos S, Garzotto M, et al. Statins and prostate cancer risk: a case-control study. Am J Epidemiol. 2005;162(4):318-325.
7. Murtola TJ, Tammela TL, Lahtela J, Auvinen A. Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2226-2232.